Catalyst Wire Dossier Catalyst Wire Dossier

AUR103 Calcium

AUR103 · Aurigene Discovery Technologies Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUR103 Calcium, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]

See pricing